{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:39:18Z","timestamp":1784770758589,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","award":["BR-CMM-0615-0681-DUKE"],"award-info":[{"award-number":["BR-CMM-0615-0681-DUKE"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","award":["BR-CMM-0522-0830-DUKE"],"award-info":[{"award-number":["BR-CMM-0522-0830-DUKE"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY005722"],"award-info":[{"award-number":["P30 EY005722"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY031748"],"award-info":[{"award-number":["R01 EY031748"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymthe.2025.04.035","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T23:02:57Z","timestamp":1745535777000},"page":"3746-3756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Truncated complement factor H Y402 gene therapy rescues C3 glomerulonephritis"],"prefix":"10.1016","volume":"33","author":[{"given":"Lindsey A.","family":"Chew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grigsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Garren","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Amason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Kyle","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Edward J.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Visel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tylor R.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8555-9596","authenticated-orcid":false,"given":"Catherine","family":"Bowes Rickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.04.035_bib1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/ki.2013.491","article-title":"Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways","volume":"85","author":"Wong","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.035_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.kint.2020.01.039","article-title":"The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons","volume":"98","author":"Farrah","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.035_bib3","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ymthe.2025.04.035_bib4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jamaophthalmol.2022.4401","article-title":"Prevalence of Age-Related Macular Degeneration in the US in 2019","volume":"140","author":"Rein","year":"2022","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0002-9343(83)90606-X","article-title":"Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis","volume":"74","author":"Cameron","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymthe.2025.04.035_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.ajkd.2007.11.032","article-title":"Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits","volume":"51","author":"Boyer","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ymthe.2025.04.035_bib7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.molimm.2009.02.013","article-title":"The spectrum of phenotypes caused by variants in the CFH gene","volume":"46","author":"Boon","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib8","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.kint.2022.07.035","article-title":"Factor H related proteins modulate complement activation on kidney cells","volume":"102","author":"Renner","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.035_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2012.212","article-title":"C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.035_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.semnephrol.2013.08.002","article-title":"Dense deposit disease and C3 glomerulopathy","volume":"33","author":"Barbour","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/13816810.2015.1101777","article-title":"Retinal disease in the C3 glomerulopathies and the risk of impaired vision","volume":"37","author":"Savige","year":"2016","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymthe.2025.04.035_bib12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/ki.2008.658","article-title":"Oligosaccharide composition is similar in drusen and dense deposits in membranoproliferative glomerulonephritis type II","volume":"75","author":"D\u2019souza","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.035_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/eye.2001.142","article-title":"Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis","volume":"15","author":"Mullins","year":"2001","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ymthe.2025.04.035_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ng1871","article-title":"CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration","volume":"38","author":"Li","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.04.035_bib15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ng.976","article-title":"A rare penetrant mutation in CFH confers high risk of age-related macular degeneration","volume":"43","author":"Raychaudhuri","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.04.035_bib16","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2019.09.024","article-title":"Age-Related Macular Degeneration Preferred Practice Pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2025.04.035_bib17","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/eye.2017.298","article-title":"Elusive drusen and changing terminology of AMD","volume":"32","author":"De Jong","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.ymthe.2025.04.035_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ophtha.2007.08.030","article-title":"Retinal precursors and the development of geographic atrophy in age-related macular degeneration","volume":"115","author":"Klein","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2025.04.035_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.04.035_bib20","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.035_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.04.035_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.04.035_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40246-021-00359-8","article-title":"Protective chromosome 1q32 haplotypes mitigate risk for age-related macular degeneration associated with the CFH-CFHR5 and ARMS2\/HTRA1 loci","volume":"15","author":"Pappas","year":"2021","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.ymthe.2025.04.035_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.04.035_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.670727","article-title":"CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis","volume":"12","author":"Piras","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymthe.2025.04.035_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.64.10.25","article-title":"AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model","volume":"64","author":"Grigsby","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.04.035_bib27","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1167\/iovs.11-7909","article-title":"Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera","volume":"52","author":"Clark","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.04.035_bib28","doi-asserted-by":"crossref","first-page":"18960","DOI":"10.1074\/jbc.M609636200","article-title":"Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism","volume":"282","author":"Herbert","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.035_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajpath.2014.08.026","article-title":"Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice","volume":"185","author":"Ding","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib31","doi-asserted-by":"crossref","first-page":"E3040","DOI":"10.1073\/pnas.1424391112","article-title":"Regulation of age-related macular degeneration-like pathology by complement factor H","volume":"112","author":"Toomey","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.035_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ki.2010.132","article-title":"Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice","volume":"78","author":"Fakhouri","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.035_bib33","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1073\/pnas.1814014116","article-title":"Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice","volume":"116","author":"Landowski","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.035_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ki.2012.80","article-title":"C3 glomerulopathy: what\u2019s in a name?","volume":"82","author":"D\u2019Agati","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.035_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy \u2014 understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0161-5890(99)00101-7","article-title":"FHL-1\/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated","volume":"36","author":"Friese","year":"1999","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.035_bib38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1089\/hum.2010.194","article-title":"Evaluation of adeno-associated viral vectors for liver-directed gene transfer in dogs","volume":"22","author":"Bell","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.04.035_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/humc.2013.082","article-title":"Biodistribution of AAV8 vectors expressing human low-density lipoprotein receptor in a mouse model of homozygous familial hypercholesterolemia","volume":"24","author":"Chen","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.04.035_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.035_bib41","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.molimm.2009.03.030","article-title":"Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase","volume":"46","author":"Paix\u00e3o-Cavalcante","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib42","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","article-title":"Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation","volume":"120","author":"Mart\u00ednez-Barricarte","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.04.035_bib43","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1681\/ASN.2015040348","article-title":"A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H","volume":"27","author":"Chauvet","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib44","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ki.1986.278","article-title":"H deficiency in two brothers with atypical dense intramembranous deposit disease","volume":"30","author":"Levy","year":"1986","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.035_bib45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","article-title":"Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)","volume":"70","author":"Licht","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.035_bib46","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jmg.2005.038315","article-title":"Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)","volume":"43","author":"Abrera-Abeleda","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymthe.2025.04.035_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.omtm.2022.12.011","article-title":"Induction of antigen-specific tolerance by hepatic AAV immunotherapy regardless of T cell epitope usage or mouse strain background","volume":"28","author":"Keeler","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.04.035_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2017.12.002","article-title":"Liver induced transgene tolerance with AAV vectors","volume":"342","author":"Keeler","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib49","doi-asserted-by":"crossref","first-page":"13345","DOI":"10.1074\/jbc.M117.795088","article-title":"Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation","volume":"292","author":"Kerr","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.035_bib50","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.04.035_bib51","doi-asserted-by":"crossref","first-page":"30716","DOI":"10.1074\/jbc.M004569200","article-title":"Type IV collagen of the glomerular basement membrane. Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains","volume":"275","author":"Boutaud","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.035_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2009.08.003","article-title":"The dynamic nature of Bruch\u2019s membrane","volume":"29","author":"Booij","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2025.04.035_bib53","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1074\/jbc.RA119.012305","article-title":"High-density lipoproteins are a potential therapeutic target for age-related macular degeneration","volume":"295","author":"Kelly","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.035_bib54","first-page":"608","article-title":"Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice","volume":"118","author":"Rose","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.04.035_bib55","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/bjo.2010.199216","article-title":"C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration","volume":"95","author":"Bhutto","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.04.035_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-62703-080-9_25","article-title":"Adeno-associated viral vectors for gene therapy of inherited retinal degenerations","volume":"935","author":"Flannery","year":"2013","journal-title":"Methods Mol. Biol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625003144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625003144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:28:26Z","timestamp":1783020506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625003144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1525001625003144"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.035","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Truncated complement factor H Y402 gene therapy rescues C3 glomerulonephritis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}